Form 8-K - Current report:
SEC Accession No. 0001193125-25-132299
Filing Date
2025-05-30
Accepted
2025-05-30 17:14:06
Documents
14
Period of Report
2025-05-30
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d18018d8k.htm   iXBRL 8-K 30028
2 EX-99.1 d18018dex991.htm EX-99.1 24981
6 GRAPHIC g18018g0530222705446.jpg GRAPHIC 3587
  Complete submission text file 0001193125-25-132299.txt   184070

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zyme-20250530.xsd EX-101.SCH 2856
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyme-20250530_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyme-20250530_pre.xml EX-101.PRE 11265
16 EXTRACTED XBRL INSTANCE DOCUMENT d18018d8k_htm.xml XML 3629
Mailing Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709
Business Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709 302-274-8744
Zymeworks Inc. (Filer) CIK: 0001937653 (see all company filings)

EIN.: 883099146 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41535 | Film No.: 251012200
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)